388 related articles for article (PubMed ID: 27689859)
1. Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis.
Qu LH; Jiang H; Chen JH
Ann Med; 2017 Mar; 49(2):142-156. PubMed ID: 27689859
[TBL] [Abstract][Full Text] [Related]
2. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy for hyperuricemia in hypertensive patients.
Gois PH; Souza ER
Cochrane Database Syst Rev; 2013 Jan; (1):CD008652. PubMed ID: 23440832
[TBL] [Abstract][Full Text] [Related]
4. The Association of Febuxostat Compared With Allopurinol on Blood Pressure and Major Adverse Cardiac Events Among Adult Patients With Hyperuricemia: A Meta-analysis.
Barrientos-Regala M; Macabeo RA; Ramirez-Ragasa R; Pestaño NS; Punzalan FER; Tumanan-Mendoza B; Castillo RR
J Cardiovasc Pharmacol; 2020 Oct; 76(4):461-471. PubMed ID: 32675751
[TBL] [Abstract][Full Text] [Related]
5. Pharmacotherapy for hyperuricemia in hypertensive patients.
Gois PHF; Souza ERM
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD008652. PubMed ID: 28406263
[TBL] [Abstract][Full Text] [Related]
6. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
7. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.
Feig DI; Soletsky B; Johnson RJ
JAMA; 2008 Aug; 300(8):924-32. PubMed ID: 18728266
[TBL] [Abstract][Full Text] [Related]
8. Effect of Uric Acid Lowering on Renin-Angiotensin-System Activation and Ambulatory BP: A Randomized Controlled Trial.
McMullan CJ; Borgi L; Fisher N; Curhan G; Forman J
Clin J Am Soc Nephrol; 2017 May; 12(5):807-816. PubMed ID: 28320765
[TBL] [Abstract][Full Text] [Related]
9. Four-week effects of allopurinol and febuxostat treatments on blood pressure and serum creatinine level in gouty men.
Kim HA; Seo YI; Song YW
J Korean Med Sci; 2014 Aug; 29(8):1077-81. PubMed ID: 25120316
[TBL] [Abstract][Full Text] [Related]
10. Potency on lowering serum uric acid in gout patients: a pooled analysis of registrative studies comparing febuxostat vs. allopurinol.
Cutolo M; Cimmino MA; Perez-Ruiz F
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4186-4195. PubMed ID: 29028079
[TBL] [Abstract][Full Text] [Related]
11. Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions.
Kanbay M; Ozkara A; Selcoki Y; Isik B; Turgut F; Bavbek N; Uz E; Akcay A; Yigitoglu R; Covic A
Int Urol Nephrol; 2007; 39(4):1227-33. PubMed ID: 17701281
[TBL] [Abstract][Full Text] [Related]
12. The impact of serum uric acid reduction on renal function and blood pressure in chronic kidney disease patients with hyperuricemia.
Tsuji T; Ohishi K; Takeda A; Goto D; Sato T; Ohashi N; Fujigaki Y; Kato A; Yasuda H
Clin Exp Nephrol; 2018 Dec; 22(6):1300-1308. PubMed ID: 29700702
[TBL] [Abstract][Full Text] [Related]
13. Effects of blood pressure lowering on outcome incidence in hypertension: 2. Effects at different baseline and achieved blood pressure levels--overview and meta-analyses of randomized trials.
Thomopoulos C; Parati G; Zanchetti A
J Hypertens; 2014 Dec; 32(12):2296-304. PubMed ID: 25259547
[TBL] [Abstract][Full Text] [Related]
14. Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients (NU-FLASH Trial).
Sezai A; Soma M; Nakata K; Hata M; Yoshitake I; Wakui S; Hata H; Shiono M
Circ J; 2013; 77(8):2043-9. PubMed ID: 23676888
[TBL] [Abstract][Full Text] [Related]
15. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
16. Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia.
Kohagura K; Tana T; Higa A; Yamazato M; Ishida A; Nagahama K; Sakima A; Iseki K; Ohya Y
Hypertens Res; 2016 Aug; 39(8):593-7. PubMed ID: 27075830
[TBL] [Abstract][Full Text] [Related]
17. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
[TBL] [Abstract][Full Text] [Related]
18. Allopurinol initiation and change in blood pressure in older adults with hypertension.
Beattie CJ; Fulton RL; Higgins P; Padmanabhan S; McCallum L; Walters MR; Dominiczak AF; Touyz RM; Dawson J
Hypertension; 2014 Nov; 64(5):1102-7. PubMed ID: 25135183
[TBL] [Abstract][Full Text] [Related]
19. Febuxostat compared with allopurinol in patients with hyperuricemia and gout.
Becker MA; Schumacher HR; Wortmann RL; MacDonald PA; Eustace D; Palo WA; Streit J; Joseph-Ridge N
N Engl J Med; 2005 Dec; 353(23):2450-61. PubMed ID: 16339094
[TBL] [Abstract][Full Text] [Related]
20. To Treat or Not to Treat? Effect of Urate-Lowering Therapy on Renal Function, Blood Pressure and Safety in Patients with Asymptomatic Hyperuricemia: A Systematic Review and Network Meta-Analysis.
Tien YY; Shih MC; Tien CP; Huang HK; Tu YK
J Am Board Fam Med; 2022; 35(1):140-151. PubMed ID: 35039419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
